Literature DB >> 21471832

Predictors of hearing loss after gamma knife radiosurgery for vestibular schwannomas: age, cochlear dose, and tumor coverage.

Melandee Brown1, Michael Ruckenstein, Douglas Bigelow, Kevin Judy, Vasthi Wilson, Michelle Alonso-Basanta, John Y K Lee.   

Abstract

BACKGROUND: Deterioration in hearing after Gamma Knife radiosurgery of vestibular schwannomas is a well-documented risk. Recent studies suggest a correlation between cochlear radiation dose and hearing preservation.
OBJECTIVE: This study identifies additional variables that predict hearing loss after radiosurgery.
METHODS: Retrospective analysis of 53 patients with audiogram follow-up. Median marginal tumor dose was 12.5 Gy. Mean tumor volume was 1.11 cm. Statistical analysis included multivariate stepwise backward linear regression and multivariate logistic regression. Variables included age, prescription dose, tumor volume, intracanalicular length, and maximum and mean cochlear dose. Dose volume histograms were generated. The percentage of the cochlear volume that received 3.6 Gy or greater, 4.7 Gy or greater, and 5.3 Gy or greater was calculated. Plan conformality indicators were calculated.
RESULTS: Forty-two patients had a less than 20-dB change in their pure tone average, with a hearing preservation rate of 79%. Two statistically significant predictors of hearing loss were identified using multivariate analysis: tumor coverage (odds ratio: 1.38 × 10) and age (odds ratio: 1.1 per year). Multivariate linear regression was used to predict change in pure tone average. Age and percentage of the cochlear volume receiving 5.3 Gy or greater were found to be statistically significant predictor variables.
CONCLUSION: Older patients are more vulnerable to detrimental effects of Gamma Knife radiosurgery on hearing. We propose that cochlear dose volume histograms be created and used to reduce the percentage of the cochlear volume exposed to radiation doses greater than 5.3 Gy. This is the first report to suggest that the conformity index tumor coverage may be an important predictor of hearing outcomes.

Entities:  

Mesh:

Year:  2011        PMID: 21471832     DOI: 10.1227/NEU.0b013e31821a42f3

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  12 in total

1.  Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.

Authors:  Kunal S Patel; Edwin Ng; Taranjit Kaur; Tyler Miao; Tania Kaprealian; Percy Lee; Nader Pouratian; Michael T Selch; Antonio A F De Salles; Quinton Gopen; Stephen Tenn; Isaac Yang
Journal:  J Neurooncol       Date:  2019-09-24       Impact factor: 4.130

2.  Systematic Review of Normal Tissue Complication Models Relevant to Standard Fractionation Radiation Therapy of the Head and Neck Region Published After the QUANTEC Reports.

Authors:  N Patrik Brodin; Rafi Kabarriti; Madhur K Garg; Chandan Guha; Wolfgang A Tomé
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-09-29       Impact factor: 7.038

3.  Health Care Utilization in Patients Undergoing Repeat Stereotactic Radiosurgery for Vestibular Schwannoma with 5-Year Follow-up: A National Database Analysis.

Authors:  Nicholas Dietz; Mayur Sharma; Beatrice Ugiliweneza; Dengzhi Wang; Maxwell Boakye; Brian Williams; Norberto Andaluz
Journal:  J Neurol Surg B Skull Base       Date:  2020-09-10

4.  Treatment Outcomes for Single Modality Management of Glomus Jugulare Tumors With Stereotactic Radiosurgery.

Authors:  Mitchell R Dobberpuhl; Stevie Maxwell; Jonathan Feddock; William St Clair; Matthew L Bush
Journal:  Otol Neurotol       Date:  2016-10       Impact factor: 2.311

5.  Impact of Cochlear Dose on Hearing Preservation following Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy for the Treatment of Vestibular Schwannoma.

Authors:  Lawrance K Chung; Nolan Ung; John P Sheppard; Thien Nguyen; Carlito Lagman; Winward Choy; Stephen Tenn; Nader Pouratian; Percy Lee; Tania Kaprealian; Michael Selch; Antonio De Salles; Quinton Gopen; Isaac Yang
Journal:  J Neurol Surg B Skull Base       Date:  2017-11-10

6.  Systematic Review of Hearing Preservation After Radiotherapy for Vestibular Schwannoma.

Authors:  Adam R Coughlin; Tyler J Willman; Samuel P Gubbels
Journal:  Otol Neurotol       Date:  2018-03       Impact factor: 2.311

7.  Surgical approaches to tinnitus treatment: A review and novel approaches.

Authors:  Teo Soleymani; David Pieton; Patrick Pezeshkian; Patrick Miller; Alessandra A Gorgulho; Nader Pouratian; Antonio A F De Salles
Journal:  Surg Neurol Int       Date:  2011-10-29

8.  Clinical evaluation of CyberKnife in the treatment of vestibular schwannomas.

Authors:  Jo-Ting Tsai; Jia-Wei Lin; Chien-Min Lin; Yuan-Hao Chen; Hsin-I Ma; Yee-Min Jen; Yi-Hsun Chen; Da-Tong Ju
Journal:  Biomed Res Int       Date:  2013-11-10       Impact factor: 3.411

9.  Outcome of hearing preservation related to tumor morphologic analysis in acoustic neuromas treated by gamma knife radiosurgery.

Authors:  Szu-Yen Pan; Shih-An Liu; Ming-Hsi Sun; Hsi-Kai Tsou; Shinh-Dung Lee; Yen-Ju Chen; Jason Sheehan; Meei-Ling Sheu; Hung-Chuan Pan
Journal:  Radiat Oncol       Date:  2017-08-15       Impact factor: 3.481

10.  A meta-analysis of treatment of vestibular schwannoma using Gamma Knife radiosurgery.

Authors:  Bartosz Rykaczewski; Miroslaw Zabek
Journal:  Contemp Oncol (Pozn)       Date:  2014-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.